Vantage Press & Media
Vantage Oncology Partners with Atlantic Urological Associates to Provide Patients Advanced Urology and Radiation Oncology Services at
Southeast Regional Prostate Cancer Treatment Center
MANHATTAN BEACH, Calif. (November 3, 2011) – Vantage Oncology, a Manhattan Beach, Calif.-based developer and operator of state-of-the-art radiation oncology centers, has announced its partnership with Atlantic Urological Associates (AUA) in Daytona, Fla. to provide local patients comprehensive urology and radiation therapy treatments at Southeast Regional Prostate Cancer Treatment Center in Daytona Beach, Fla.
“Our partnership with AUA provides us a tremendous opportunity to collaborate with one of Florida’s top urology groups,” said Michael T. Fiore, CEO of Vantage Oncology. “In combination with the expertise of AUA physicians and clinical staff, I am confident that together we can continue to build upon the clinical successes achieved at its Southeast Regional Prostate Cancer Treatment Center.”
AUA is a professional corporation of board certified urologists who are represented in several prestigious professional medical organizations including the American College of Surgeons, American Urological Association, American Lithotripsy Society and various county, state and national medical associations. In addition to its urologists, AUA also includes a board certified pathologist who possesses extensive clinical experience in urological pathology.
“We are excited about our new partnership with Vantage Oncology because it provides us a great opportunity to continue to enhance the quality of service we deliver to our patients in the area of radiation oncology,” said Michael Grable, M.D. F.A.C.S., President and CEO of Atlantic Urological Associates. “Our group considered many partners, but Vantage Oncology stands out as an organization that has the extensive resources and knowledge to help us continue to offer leading edge care to our patients.”
"We are excited about our affiliation with the physicians of AUA. It creates an expanding multidisciplinary cancer program, led by the top prostate cancer physicians in Daytona and clearly compliments our growing network of affiliated centers in the Florida market" commented Les Botnick, M.D., Chief Medical Officer of Vantage Oncology.
The Southeast Regional Prostate Cancer Treatment Center is the first state-of-the-art facility of its kind in Daytona Beach and it combines innovative radiation therapy treatments with patient-centered care. The clinical team is comprised of AUA board-certified physicians including the most experienced prostate cancer radiation oncologist in the area. Patients have access to today’s most advanced and clinically proven radiation therapy technologies such as Intensity Modulated Radiation Therapy (IMRT), Image Guided Radiation Therapy (IGRT), Stereotactic body radiation therapy (SBRT) and Stereotactic Radiosurgery (SRS).
About Vantage Oncology
Founded in October 2002, Vantage Oncology develops and operates radiation oncology centers of excellence through acquisitions and joint ventures. The company was founded because of a growing need among cancer patients, hospitals and physicians for easily accessible and advanced radiation treatment therapies. Vantage Oncology currently operates 46 treatment facilities in 13 states throughout the United States. Vantage Oncology is led by a seasoned management team including Chief Executive Officer Michael Fiore, Chief Medical Officer Leslie Botnick, M.D., Chief Financial Officer Marshal Salomon and Chief Development Officer Mark Ahern. For more information about Vantage Oncology, visit www.vantageoncology.com.
Contact:
Trace Longo
Longo Communications
Office: 949.364.2821
E-mail: trace.longo@sbcglobal.net
Vantage Oncology
Marketing Department
Office: 310-335-4000
|
